# Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

> **NCT00470366** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 60 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Extragonadal Germ Cell Tumor
- Ovarian Cancer
- Teratoma
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** pegfilgrastim
- **DRUG:** cisplatin
- **DRUG:** ifosfamide
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00470366
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470366, "Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00470366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*